Pharm.D, BCPS, BCOP
Resume:
Pharmacy Education
Oncology Post-Graduate Year 2 (PGY2) Residency, Cone Health
Cancer Center (CHCC), Greensboro, NC; Program Director: Lew Iacovelli, BS, Pharm.D., BCOP, CPP; Bone Marrow Transplant and Pediatric Oncology rotations completed at Wake Forrest Baptist Health under the supervision of LeAnne Kennedy, Pharm.D., BCOP and Brandy Strickland Snyder, Pharm.D., BCOP
July 2010-June 2011 Pharmacy Practice Post-Graduate Year 1 Residency, Phoebe Putney Memorial Hospital (PPMH); Program Director: Rodolph A. Gilmore, III, R.Ph., BSPharm
July 2010-June 2011 Certificate in Clinical Pharmacy and Teaching Certificate Program, University of Georgia (UGA); Program Director: Bradley Phillips, Pharm.D., BCPS, FCCP
August 2001-May 2005 University of Georgia, College of Pharmacy, Athens, GA Doctor of Pharmacy: Awarded May 2005
Certifications and Licensing
December 2013-Present Board Certified Oncology Pharmacist, 5133016 December 2012-Present Board Certified Pharmacotherapy Specialist, 3121388 May 2012-Present Pharmacist, State of South Carolina license, 13683 May 2012-Present Pharmacist, State of Florida license, PS48909 July 2011-Present Pharmacist, State of North Carolina license, 22048 August 2005-Present Pharmacist, State of Georgia license RPH022759 June 2003-Present American Pharmacists Association Immunization Certification September 2001-Present American Heart Association Healthcare BLS Provider Nancy M. Nix, Pharm.D., BCPS, BCOP
2451 Hawthorne Lane
Gainesville, GA 30506
*********@*****.***
Nancy M. Nix-Page 2 of 10
Pharmacy Related Employment History
July 2015-Present Clinical Assistant Professor of Clinical and Administrative Pharmacy, University of Georgia, Athens, GA
January 2013-2016 Concept Originator and Oncology Product Advisor, Looking Glass Software, Cincinnati, OH
July 2012-Present Oncology Pharmacy Clinical Coordinator, St. Joseph’s/Candler Health System, Inc. (SJCHS), Savannah, GA July 2012-Present Supervising Investigational Pharmacist, South Carolina Cancer Specialists, Hilton Head Island, SC July 2011-June 2012 PGY2 Oncology Pharmacy Resident: Moses Cone Health System, Greensboro, NC
July 2010-June 2011 PGY1 Pharmacy Practice Resident: Phoebe Putney Memorial Hospital, Albany, GA
Graduate Teaching Assistant completing the teaching certificate program: University of Georgia, Athens, GA
February 2009-June 2011 Clinical Pharmacist, St. Joseph’s/Candler Health System, Savannah, GA January 2009-April 2011 PRN Staff Pharmacist, CVS Pharmacy, Savannah, GA June 2005-January 2009 Pharmacy Manager, Wal-Mart #605, Savannah, GA January 2001-May 2005 Licensed Pharmacy Intern (Part-time), Wal-Mart Pharmacies, Athens and Savannah, GA
December 2001-May 2005 Research Assistant (Part-time), UGA College of Pharmacy, Athens, GA Clinical Education Affiliations
March 2015-Present
Faculty Advisor, Student Oncological Advocates in Pharmacy (SOAP) University of Georgia, College of Pharmacy
July 2012-Present University of Georgia, College of Pharmacy, Athens, GA July 2012-Present South University, College of Pharmacy, Columbia, SC/Savannah, GA July 2012-Present Mercer University, College of Pharmacy, Atlanta, GA Current Professional Memberships
Advanced Practitioner Society for Hematology and Oncology (APSHO)-Founding Member American College of Clinical Pharmacy (ACCP)
American Society of Clinical Oncology (ASCO)
Nancy M. Nix-Page 3 of 10
Association of South Carolina Oncology Managers (ASCOM) American Society of Health-System Pharmacists (ASHP) Hematology/Oncology Pharmacy Association (HOPA)
North Carolina Oncology Pharmacists Association (NCOP) Peer Reviewed Publication Contributions
Anticipated May 2019 Multiple Myeloma: A Retrospective, Multi-Site, Regional Analysis of Best Pharmacotherapeutic Practices in the Prevention of Skeletal Related Events, Abtract 255, Journal of the American Pharmacists Association
January 2019 ASHP/ACCP 2019 Oncology Pharmacy Preparatory Review and Recertification Course-Reviewer
November 2018 Concept development: Understanding the Role of Targets and Pathways in the Treatment of Melanoma, JADPRO
November 2018 JADPRO Live at APSHO: Top Poster Judge September 2018 ASCO Case Based Item Writer
August 2018 2018 ACCP/ASHP BCOP Clinical Sessions presentations (with a focus on Cardiology)- Reviewer
August 2018 JADPRO Live at APSHO: Submitted abstract reviewer August 2018 Dr. Neil Love and Research To Practice (RTP): Prevalence and clinical implications of inaccurate or misclassified lymphoma diagnosis-Reviewer and evaluator
December 2017 BPS Oncology Item Writer
November 2017 JADPRO Live at APSHO: On site poster reviewer November 2015 Kurtin SE, Peterson M, Goforth P, May MB, Viale PH, Smith WJ, Rust D, Grande C, Nix NM, Bishop CS: WHITE PAPER: The Advanced Pracitioner and Collaborative Practice in Oncology. J Adv Pract Oncol 2015;6:515-527
March 2015 Nix NM, Brown K. Ceritinib for ALK-Rearrangement–Positive Non– Small Cell Lung Cancer. J Adv Pract Oncol 2015;6:156–160 July 2014 Nix NM, Burdine O, Walker M. Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma. J Adv Pract Oncol 2014;5:294–296 January 2014-March 2014 BPS Oncology Item Writer
January 2014 Nix NM, Braun K. Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma. J Adv Pract Oncol 2014;5:47-50 Nancy M. Nix-Page 4 of 10
March 2013 Fleming V, Buck B, Nix NM, Kumar P, Southwood R. Community- acquired pneumonia with risk for drug-resistant pathogens. South Med J. 2013 Mar;106(3):209-16.
August 2012-Present Editorial Board, Journal of the Advanced Practitioner in Oncology Industry Involvement
March 2019-December 2019 Coherus Biosimilar Speakers Bureau, Miami, FL November 2018 Moderator-Puma Advisory Board at APSHO, Hollywood, FL March 2018 Bristol-Meyers Squibb HOPA Advisory Board, Denver, CO March 2018 Sandoz Scientific Advisory Board at HOPA, Denver, CO January 2018 Ipsen Pancreatic Strategic Council Meeting at ASCO GI, San Francisco, CA
January 2018 APSHO Industry Council Expert Panel
November 2016 Genentech Pharmacy Advisory Board Meeting, San Francisco, CA November 2016 Sandoz Biosimilar Medical Advisory Board Meeting, San Francisco, CA August 2015 Teva Bendeka Advisory Board Meeting, Philadelphia, PA Committee Memberships
December 2021-October 2022 Immediate past-chair, Education Committee, JADPRO Live at APSHO national convention
November 2019-November 2021 Education Committee chairperson, JADPRO Live at APSHO national convention
April 2019-October 2019 Chair-Elect, Education Committee, JADPRO Live at APSHO national convention
September 2018-Present Faculty: ASCO & National Board of Medical Examiners Question Writing Team April 2018-Present HOPA BCOP Question Field Tester January 2018-Present APSHO Industry Council
September 2017-Present APSHO Mentorship Task Force May 2017-April 2018 HOPA Tools and Resources
April 2017-June 2019 APSHO Education Committee
August 2016-Present Chair, New Drug Review Education-ASCOM July 2016-June 2020 Co-Chair-Priming the Pump Task Force-APSHO Nancy M. Nix-Page 5 of 10
May 2016-April 2017 Program-Session Proposal Review Work Group-HOPA April 2015-November 2015 Advanced Practitioner Role Delineation Committee-ASCO/APSHO October 2014-Present Continuing Education Committee-APSHO December 2012-January 2013 ACCP Focus Session Committee Member April 2012-Present PGY1 Residency Curriculum Committee-SJCHS July 2012-Present Advanced Pharmacy Practice Experience Preceptor Committee-SJCHS July 2012-Present Chairperson, Oncology Review Panel-SJCHS July 2011-June 2012 Oncology Pharmacy Task Force-CHCC July 2011-June 2012 Oncology BUS Team-CHCC
July 2011-June 2012 Greensboro Cancer Study Group-CHCC July 2010-June 2011 Pharmacy and Therapeutics Committee-PPMH Research
April 2018-Present Retrospective analysis of the initiation of bone modifying agents at diagnosis for patients with Multiple Myeloma and the rates of skeletal related events in a multi-site community health system. St. Joseph’s/Candler Health System, Inc August 2015-June 2016 Novel oral anticoagulants compared to the standard of care for the chronic management of recurrent venous thromboembolism in oncology patients: a retrospective observational analysis. St. Joseph’s/Candler Health System, Inc. August 2014-Present Financial Implications of the Implementation of Mandatory Dose Rounding of Monoclonal Antibodies. St. Joseph’s/Candler Health System, Inc. July 2013-April 2014 Retrospective Analysis of the Incidence of Bendamustine Associated Hematologic Toxicities: St. Joseph’s/Candler Health System, Inc. July 2012-April 2013 A Retrospective Chart Review of the Administration Schedule of Azacitidine and Patient Outcomes: St. Joseph’s/Candler Health System, Inc. July 2011-April 2012 Compounded Diclofenac Cream for Aromatase Inhibitor-Induced Arthralgia: Cone Health Cancer Center
July 2010-April 2011 Community-acquired pneumonia with risk for drug-resistant pathogens: Phoebe Putney Health System
August 2003-May 2004 Assessment of Patient Valuation of Antiemetic Therapies: University of Georgia Research Assistant
June 2002 Assessment of Community Pharmacists Knowledge, Skill, Comfort, and Interests in Performing Cancer Awareness and Prevention Activities University of Georgia Research Assistant
Nancy M. Nix-Page 6 of 10
Professional Meeting Presentations
March 2019 Podium presentation: Multiple Myeloma: A Retrospective, Multi-Site, Regional Analysis of Best Pharmacotherapeutic Practices in the Prevention of Skeletal Related Events, Abtract 255, American Pharmacists Association Annual Meeting (National)
March 2019 Cardiac implications of oncology agents and their management, Grand Rounds, University of Georgia (State)
April 2017 Strategies to Improve Oral Chemotherapy Compliance, Grand Rounds, University of Georgia (State)
March 2017 Financial Managers Opportunity to Impact Oral Chemotherapy Access and Adherence, Association of South Carolina Oncology Managers
(State)
October 2016 Mindful Motivation: Improving oncology oral chemotherapy compliance. Southeast Georgia Oncology Nursing Society Annual Conference, Savannah, GA (Regional)
September 2016
Investing Early to Maximize Retirement Benefits. Student Oncological Advocates in Pharmacy Quarterly Meeting, Savannah, GA (Regional) January 2016
2015 Oncology Oral Agents: The year in review. Association of South Carolina Oncology Managers, Columbia, SC (State)
October 2015 Oral agents for the treatment of melanoma and basal cell carcinoma: Treatment, Monitoring and Toxicity Management. Southeast Georgia Oncology Nursing Society Annual Conference, Savannah, GA August 2015 Targeted oral cancer therapies: Comparing pharmacology, toxicities, and potential limitations. Smith Drug Wholesale Annual Continuing Education Conference, Savannah, GA (National)
October 2014 Oral Analgesics and Antiemetics for Patients with Head and Neck Cancers. Southeast Georgia Oncology Nursing Society Annual Conference, Savannah, GA (Regional)
March 2014 Finally, compounding software that makes sense to a pharmacist! Hematology/Oncology Pharmacy Association 10th Annual Conference, New Orleans, LA (National)
April 2012
A randomized, double-blind, placebo controlled study of the effect of diclofenac sodium 1% cream on aromatase inhibitor-induced arthralgia. ACPE CE 0.25 live credit hours. Southeastern Residency Conference, Athens, GA (Regional)
April 2012 Oncology Overview. University of North Carolina at Greensboro, Department of Kinesiology. (Local)
March 2012
A randomized, double-blind, placebo controlled study of the effect of diclofenac sodium 1% cream on aromatase inhibitor-induced arthralgia. Hematology/Oncology Pharmacy Association 8th Annual Conference, Orlando, FL (National)
Nancy M. Nix-Page 7 of 10
February 2012 Hot Topics: 2011 Oncology drug update. ACPE CE 1.0 live credit hours. Greensboro Area Health Education Center, Greensboro, NC (Regional) February 2012 2011 Oncology nursing drug update. 1.0 CEU. CHCC, Greensboro, NC
(Local)
December 2011 A randomized, double-blind, placebo controlled study of the effect of diclofenac sodium 1% cream on aromatase inhibitor-induced arthralgia. American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA (National)
May 2011 Evaluation of empiric antibiotic therapy for treatment of pneumonia in a community hospital. ACPE CE 1.0 live credit hours. Georgia Society of Health-System Pharmacists, Southwest (Regional)
April 2011 Evaluation of empiric antibiotic therapy for treatment of pneumonia in a community hospital. ACPE CE 0.25 live credit hours. Southeastern Residency Conference, Athens, GA (Regional)
Residency Presentations
June 2012 Journal club: EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. CHCC
June 2012 Drug review: Dactinomycin. CHCC
May 2012 Journal Club: CALGB 90401: Docetaxel and prednisone with or without bevacizumab for metastatic castration-resistant prostate cancer. CHCC Journal club: Appropriate Chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline. WFBH
April 2012 Journal club: Prostate cancer mortality at 11 years of follow up. CHCC Intraperitoneal chemotherapy administration review. CHCC Journal club: Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. CHCC Drug review: Common intraperitoneal regimens. CHCC March 2012 Drug review: Cetuximab. CHCC
Journal club: Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label randomized controlled trial. CHCC
Drug review: Oxaliplatin. CHCC
February 2012 Chemotherapy for the management of gestational trophoblasicdisease. CHCC
Nancy M. Nix-Page 8 of 10
Drug review: Mitomycin. CHCC
Disease state review: Gestational trophoblastic disease. CHCC Drug class review: Vinca Alkaloids. CHCC
January 2012 Oncology team innovative therapy update: Loratadine for pegfilgrastim induced bone pain WFBH
December 2011
December 2011
Drug review: Clofarabine. CHCC
Journal club: A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma. CHCC
Drug review: Mitoxantrone. CHCC
Journal Club: Erlotinib versus chemotherapy as first0line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicenter, open-label, randomized, phase 3 study
November 2011
Research review: CHCC Lung Cancer Clinical Trials Overview Drug review: Crizotinib. CHCC
Journal club: Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy (FORTIS-M). CHCC
Drug review: Pemetrexed. CHCC
Community outreach: Pain Management Considerations in Cancer. Advanced Cancer Support Group. CHCC
October 2011
Research review: Breast Cancer Clinical Trials Overview CHCC Journal club: Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography. CHCC Drug review: Lapatinib. CHCC
Treatment debate: TC vs. AC: Which is the better choice for breast cancer patients? CHCC
Journal club: Combination chemotherapy as an adjuvant treatment in operable breast cancer. CHCC
Investigational Drug review: Iniparib. CHCC
September 2011 Community outreach: Prostate Cancer Treatment Update. CHCC Prostate Cancer Support Group.
Drug review: Paclitaxel. CHCC
Nancy M. Nix-Page 9 of 10
Journal club: Phase II study of biweekly paclitaxel plus infusional 5- fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer. CHCC
Drug review: Vemurafenib. CHCC
Journal club: Abiraterone and increased survival in metastatic prostate cancer. CHCC
August 2011 Drug review: Methotrexate. CHCC
Journal club: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. CHCC
Drug review: Bleomycin. CHCC
Journal club: Everolimus for advanced pancreatic neuroendocrine tumors. CHCC
July 2011 Drug review: Vandetinib. CHCC
*Additional presentations prior to specialty residency available by request Honors and Awards
2013-2018: University of Georgia, College of Pharmacy: Preceptor of the year nominee 2013-2018: South University, College of Pharmacy: Preceptor of the year nominee 2013-2016: Mercer University, College of Pharmacy: Preceptor of the year nominee 2015: National Pharmacist Spokesperson for the Advanced Practitioner Society for Hematology and Oncology February 2015: Cancer Center Profile, The Oncology Pharmacist 2012: HOPA 8th Annual meeting travel grant recipient, Orlando, FL 2005: Recipient of the Kenneth L. Waters Award that is awarded to one student annually who represents academic excellence, leadership qualities, professional attitude, and in service to the profession, college and community
2001-2005: Dean’s or President’s List for all semesters 2004: Elected by classmates as “Most likely to succeed” and “Most likely to own her own pharmacy” 2003-Present: Vice-President, Class of 2005
2001-2003: Class Representative: One of two elected by our class of 125-****-****: Dean’s Student Advisory Council: Composed of the president and vice-president from each student organization as well as the elected class representatives. The goal is to promote student involvement in the college’s development.
Nancy M. Nix-Page 10 of 10
2001-2004: Student Life Advisory Council: Composed of 12 of the approximately 33,000 UGA students representing the largest student organizations. This council is chaired by the Vice-President of Student Affairs and is responsible for development of alumni relations plans, student recruitment programs, and to promote school pride.
2002-2003: Curriculum Committee Student Representative March 2004: National Representative for UGA in the ASP Patient Counseling Competition, Seattle, WA February 2004: First-Place-local ASP Patient Counseling Competition December 2003: National Representative for UGA in the ASHP Clinical Skills Competition, New Orleans, LA Fall 2003: Class of 2005 Most likely to succeed and Most likely to own my own pharmacy awards from my classmates
Fall 2003: Student Leadership Profile: Each quarter one student is profiled in the Georgia Pharmacist Quarterly alumni magazine. It is a great honor to be chosen as only those students who exhibit academic excellence while also being involved with professional organizations are chosen. November 2003: First Place-local ASHP Clinical Skills Competition Spring 2003: First Runner-up local APhA National Patient Counseling Competition 2001, 2002, 2003, and 2004: Who’s Who Among Students in American Universities and Colleges Current Volunteer Involvement
SOAR Special Recreation Special Olympics Relay-for-life
Contact this candidate